ssh stock rise vs htwr stock decline

Thought id pick up on a subject to see if there is a link.

As most of you well know , Heartware is also an Australian company which made the transition to the US market , years ahead of sunshine heart and managed to gain some of the LVAD market with Thoratec . Dont want to go into much detail , but the stock of Heartware reached the borders of 100 dollars , and managed to get FDA approval on november 2012 .

Since july 2013 , SSH has gone from $5 to almost $14 and is setlling now in the $11 range . The start of the trial , good corporate updates , more market recognition , another offering which allows us to have enough funding till the commercialization of the cpulse etc

In the same time , Heartware's stock has fallen from almost $98 in july to todays price of $69.99

is there a link ? Are investors realising that SSH's market is bigger and will dominate the market ?

Are institutions realising the bigger opportunity in SSH and selling off or decreasing their positions in HTWR for entry into SSH , are institutions hedging their positions etc ?

Either way , if we have some very good data on 28-10 , we can go to the $20 level soon .

Could we be in a years time in the 50-60 dollars if the results are great , and actually exceed HTWR price at the time.

To note I have no interest in Heartware and i do not follow their stock etc , just in the sense that the market could be waking up to the true potential of the newcomer with the better , more affordable product , the cpulse.


thoughts ?